Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications

Elise Belaidi 1 Jessica Morand 1 Emmanuelle Gras 1 Jean-Louis Pépin 1 Diane Godin-Ribuot 1, *
* Auteur correspondant
1 HP2 : Hypoxie et physiopathologies cardiovasculaires et respiratoires.
Abstract : Obstructive sleep apnea (OSA) is now recognized as an independent and important risk factor for cardiovascular diseases such as hypertension, coronary heart disease, heart failure and stroke. Clinical and experimental data have confirmed that intermittent hypoxia is a major contributor to these deleterious consequences. The repetitive occurrence of hypoxia-reoxygenation sequences generates significant amounts of free radicals, particularly in moderate to severe OSA patients. Moreover, in addition to hypoxia, reactive oxygen species (ROS) are potential inducers of the hypoxia inducible transcription factor-1 (HIF-1) that promotes the transcription of numerous adaptive genes some of which being deleterious for the cardiovascular system, such as the endothelin-1 gene. This review will focus on the involvement of the ROS-HIF-1-endothelin signaling pathway in OSA and intermittent hypoxia and discuss current and potential therapeutic approaches targeting this pathway to treat or prevent cardiovascular disease in moderate to severe OSA patients.
Keywords : Oxidative stress Obstructive sleep apnea Intermittent hypoxia Hypoxia inducible factor-1 Endothelin-1 Cardiovascular disease
Type de document :
Article dans une revue
Pharmacology and Therapeutics, Elsevier, 2016, [Epub ahead of print]
Liste complète des métadonnées

Littérature citée [6 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-01369186
Contributeur : Diane Godin-Ribuot <>
Soumis le : mardi 20 septembre 2016 - 15:49:43
Dernière modification le : vendredi 25 mai 2018 - 13:40:52

Fichier

Belaidi et al. P&T 19052016 Re...
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Elise Belaidi, Jessica Morand, Emmanuelle Gras, Jean-Louis Pépin, Diane Godin-Ribuot. Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications. Pharmacology and Therapeutics, Elsevier, 2016, [Epub ahead of print]. 〈inserm-01369186〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

233

Téléchargements de fichiers

194

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD